Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-25-006409
Filing Date
2025-01-27
Accepted
2025-01-27 19:03:50
Documents
1
Period of Report
2024-12-29

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm254427-4_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm254427-4_4seq1.xml 4 10054
  Complete submission text file 0001104659-25-006409.txt   12523
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
ORBIMED ADVISORS LLC (Reporting) CIK: 0001055951 (see all company filings)

State of Incorp.: DE
Type: 4 | Act: 34 | File No.: 001-36020 | Film No.: 25560538

Mailing Address 12 PENNS TRAIL NEWTOWN PA 18940
Business Address 12 PENNS TRAIL NEWTOWN PA 18940 267-759-3680
Traws Pharma, Inc. (Issuer) CIK: 0001130598 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022-4629
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022-4629 (212) 739-6400
OrbiMed Capital GP VIII LLC (Reporting) CIK: 0001845804 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36020 | Film No.: 25560537